[Ataxia telangiectasia].
Mizutani
Shuki
S
Department of Pediatrics and Developmental Biology, Graduate School of Medicine, Tokyo Medical and Dental University.
D001260:Ataxia Telangiectasia / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D064007:Ataxia Telangiectasia Mutated Proteins; D002453:Cell Cycle / Q000235:genetics; D018797:Cell Cycle Proteins / Q000502:physiology; D004268:DNA-Binding Proteins / Q000502:physiology; D018816:Genes, cdc; D006801:Humans; D007136:Immunoglobulins / Q000008:administration & dosage; D008019:Life Style; D009369:Neoplasms / Q000209:etiology / Q000517:prevention & control; D019869:Phosphatidylinositol 3-Kinases; D011379:Prognosis; D017346:Protein Serine-Threonine Kinases / Q000502:physiology; D025521:Tumor Suppressor Proteins / Q000502:physiology
D064007:Ataxia Telangiectasia Mutated Proteins; D018797:Cell Cycle Proteins; D004268:DNA-Binding Proteins; D007136:Immunoglobulins; D019869:Phosphatidylinositol 3-Kinases; D017346:Protein Serine-Threonine Kinases; D025521:Tumor Suppressor Proteins; C576324:ATM protein, human